Phase 2 Readout
MAZE: Phase 2 Readout: mze829
December 31, 2026 · mze829. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- Maze Therapeutics, Inc. (MAZE)
- Drug
- mze829
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: mze829
- Drug
- mze829
- Indication
- broad AMKD